Congress is considering changes to the way the Food and Drug Administration handles drug safety. An FDA scientist testified that superiors pressed him to soften conclusions on the safety of profitable drugs... and that at least five drugs on the market have major problems. Hear NPR's Joanne Silberner.
Copyright 2004 NPR
